Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways

International Journal of Oncology

Volumn 33, Issue 3, 2008, Pages 493-501

  Kim, Ju Young ^a   Park, Hyun Ki ^a   Yoon, Jin Sun ^a   Kim, Seo Ju ^a   Kim, Eun Shil ^a   Ahn, Kwang Sung ^a   Kim, Dong Sun ^b   Yoon, Sung Soo ^a   Kim, Byoung Kook ^a   Lee, Young Yiul ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Acute myeloid leukemia; Advanced glycation end product; Apoptosis; Cell proliferation; MAP kinase; RAGE antisense S ODN

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; STAT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; FLOW CYTOMETRY; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BLOTTING, WESTERN; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA, MYELOID, ACUTE; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 54849187700     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000032     Document Type: Article

References (31)

1. Brownlee M, Cerami A and Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988.
2. Miyata T, Hori O, Zhang J, et al: The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98: 1088-1094, 1996.
3. Bucciarelli LG, Wendt T, Rong L, et al: RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59: 1117-1128, 2002.
4. Huttunen HJ, Fages C, Kuja-Panula. J, Ridley AJ and Rauvala H: Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62: 4805-4811, 2002.
5. Mazurek N, Conklin J, Byrd JC, Raz A and Bresalier RS: Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 275: 36311-36315, 2000.
6. Li YM, Mitsuhashi T, Wojciechowiez D, et al: Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci USA 93: 11047-11052, 1996.
7. Hirai M and Shimizu N: Purification of two distinct proteins of approximate Mr 80,000 from human epithelial cells and identification as proper substrates for protein kinase C. Biochem J 270: 583-589, 1990.
8. Stern DM, Yan SD, Yan SF and Schmidt AM: Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 1: 1-15, 2002.
9. Bierhaus A, Schiekofer S, Schwaninger M, et al: Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50: 2792-2808, 2001.
10. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA and Schmidt AM: Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814, 1997.
11. Schmidt AM, Hasu M, Popov D, et al: Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci USA 91: 8807-8811, 1994.
12. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL and Stern D: Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14: 1521-1529, 1994.
13. Miki S, Kasayama S, Miki Y, Nakamura Y, Yamamoto M, Sato B, et al: Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vitro. Biochem Biophys Res Commun 196: 984-989, 1993.
14. Kuniyasu H, Chihara Y and Kondo H: Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer 104: 722-727, 2003.
15. Kuniyasu H, Oue N, Wakikawa A, Shigeishi H, Matsutani N, Kuraoka K, et al: Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activitiy of gastirc cancer. J Pathol 196: 163-170, 2002.
16. Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W and Munch G: Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J Neurochem 87: 44-55, 2003.
17. Abe H, Matsubara T, Iehara N, Nagai K, Takahashi T, Arai H, et al: Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation. J Biol Chem 27: 14201-14206, 2004.
18. Campling BG, Pym J, Galbraith PR and Cole SP: Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. Leuk Res 12: 823-831, 1988.
19. Powell BL, Gregory BW, Kute TE, Morgan TM, Lyerly ES and Capizzi RL: Bromodeoxyuridine incorporation into DNA of human leukemia cells is not concentration dependent. Cytometry 11: 438-441, 1990.
20. Huang JS, Guh JY, Chen HC, Hung WC, Lai YH and Chuang LY: Role of receptor for advanced glycation end-product (RAGE) and the JAK/ STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 81: 102-113, 2001.
21. Cai D, Byth KF and Shapiro GI: AZ703, an imidazo[1,2-α] pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9. Cancer Res 66: 435-444, 2006.
22. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497, 1995.
23. Martinez J, Georgoff I, Martinez JA and Levine AJ: Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151-159, 1991.
24. Michalovitz D, Halevy O and Oren M: Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 671-680, 1990.
25. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, et al: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
26. Brunet A, Pages G and Pouyssegur J: Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9: 3379-3387, 1994.
27. Seger R and Krebs EG: The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
28. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, et al: Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17: 1263-1293, 2003.
29. Hsia CY, Cheng S, Owyang AM, Dowdy SF and Liou HC: C-Rel regulation of the cell cycle in primary mouse B lymphocytes. Int Immunol 14: 905-916, 2002.
30. Guttridge DC, Albanese C, Reuther JY, Pestell RG and Baldwin AS Jr: NF-kappa B controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799, 1999.
31. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C and Strauss M: NF-kappa B function in growth control: regulation of cyclin D1 expression and G0/G1-to-S -phase transition. Mol Cell Biol 19: 2690-2698, 1999.